0,904  0,005  Antiinflammatory
0,765  0,011  Teratogen
0,749  0,011  Embryotoxic
0,733  0,005  Nitric oxide antagonist
0,700  0,031  Apoptosis agonist
0,667  0,005  UGT1A4 substrate
0,621  0,013  Sensitization
0,598  0,014  CYP2C19 substrate
0,582  0,012  NOS3 expression inhibitor
0,580  0,014  Antipruritic, allergic
0,554  0,005  Sigma receptor agonist
0,544  0,004  Antiviral (Influenza A)
0,536  0,004  Antiviral (Influenza)
0,558  0,026  CYP2C9 substrate
0,547  0,021  Antihypercholesterolemic
0,523  0,005  Contraceptive
0,550  0,038  Transcription factor NF kappa B inhibitor
0,515  0,004  Abortion inducer
0,513  0,009  UGT2B4 substrate
0,529  0,025  Immunosuppressant
0,522  0,019  CYP2C19 inhibitor
0,502  0,003  UGT2B9 substrate
0,530  0,039  TNF expression inhibitor
0,508  0,018  NOS2 expression inhibitor
0,523  0,037  CYP3A4 substrate
0,480  0,006  Antiacne
0,477  0,006  UGT2B7 substrate
0,473  0,008  Hair growth stimulant
0,487  0,035  Cholesterol antagonist
0,475  0,024  AR expression inhibitor
0,453  0,007  5 Hydroxytryptamine uptake stimulant
0,494  0,055  Antineoplastic (breast cancer)
0,483  0,046  Antibacterial
0,435  0,006  Lipocortins synthesis antagonist
0,426  0,007  Antipruritic, non-allergic
0,444  0,029  Antineoplastic (pancreatic cancer)
0,450  0,037  Bone diseases treatment
0,479  0,069  Caspase 9 stimulant
0,415  0,006  Endometrios treatment
0,427  0,025  Chemopreventive
0,416  0,015  UGT1A1 substrate
0,431  0,038  Antineoplastic (ovarian cancer)
0,400  0,009  Pneumotoxic
0,421  0,033  Analeptic
0,390  0,005  Antiinfertility, female
0,389  0,012  Prostate disorders treatment
0,393  0,021  UDP-glucuronosyltransferase substrate
0,419  0,048  Prostate cancer treatment
0,395  0,030  Proliferative diseases treatment
0,377  0,025  Sodium/bile acid cotransporter inhibitor
0,405  0,064  Antineoplastic (lung cancer)
0,345  0,005  Contraceptive male
0,334  0,005  Alcohol dehydrogenase substrate
0,357  0,030  Antineoplastic (endocrine cancer)
0,369  0,044  Antiosteoporotic
0,363  0,043  Antineoplastic (cervical cancer)
0,323  0,004  UGT2B10 substrate
0,355  0,037  Carcinogenic
0,352  0,037  Antineoplastic (osteosarcoma)
0,379  0,064  Stroke treatment
0,331  0,018  Prostatic (benign) hyperplasia treatment
0,380  0,070  Antileukemic
0,326  0,016  Interferon gamma antagonist
0,312  0,003  5-Alpha-reductase inhibitor
0,361  0,053  Respiratory analeptic
0,360  0,057  Antifungal
0,335  0,037  Angiogenesis stimulant
0,345  0,053  Antiepileptic
0,289  0,005  ABCA1 expression enhancer
0,295  0,018  UGT2B15 substrate
0,279  0,003  Arachidonic acid antagonist
0,328  0,058  CTGF expression inhibitor
0,323  0,054  Antioxidant
0,320  0,051  Chemoprotective
0,294  0,025  Antialcoholic
0,298  0,033  Anesthetic general
0,319  0,061  Interleukin 2 agonist
0,262  0,004  Actinic keratosis treatment
0,264  0,009  Androgen antagonist
0,304  0,051  Tumour necrosis factor alpha release inhibitor
0,283  0,037  Antihypotensive
0,296  0,053  Free radical scavenger
0,262  0,027  Melanin inhibitor
0,312  0,078  Apoptosis antagonist
0,281  0,047  Mutagenic
0,233  0,006  Postmenopausal disorders treatment
0,290  0,064  UGT1A9 substrate
0,227  0,002  Anabolic
0,234  0,012  UGT2B1 substrate
0,266  0,043  Sedative
0,221  0,009  Opioid kappa receptor antagonist
0,315  0,103  GST A substrate
0,221  0,011  Contraceptive female
0,262  0,056  UGT1A6 substrate
0,234  0,030  Carcinogenic, group 3
0,265  0,063  Acute neurologic disorders treatment
0,293  0,092  FMO1 substrate
0,294  0,093  ICAM1 expression inhibitor
0,248  0,047  VCAM1 expression inhibitor
0,224  0,031  Skin irritative effect
0,215  0,024  Psychosexual dysfunction treatment
0,194  0,005  UGT2B11 substrate
0,207  0,018  Microtubule formation inhibitor
0,230  0,044  Antimutagenic
0,190  0,005  Androgen agonist
0,233  0,049  Hepatoprotectant
0,245  0,060  Psychostimulant
0,225  0,043  Eye irritation, high
0,217  0,037  Succinate dehydrogenase inhibitor
0,249  0,073  Cardiovascular analeptic
0,264  0,089  FMO3 substrate
0,195  0,026  Cell adhesion inhibitor
0,185  0,016  Aldehyde dehydrogenase substrate
0,214  0,045  Thrombolytic
0,187  0,019  Menstruation disorders treatment
0,182  0,014  AMP-activated protein kinase stimulant
0,192  0,025  Antieczematic
0,191  0,029  Cholesterol synthesis inhibitor
0,229  0,068  Cytotoxic
0,201  0,040  NOS3 expression enhancer
0,177  0,019  Opioid antagonist
0,277  0,121  Ulceration
0,180  0,024  Growth stimulant
0,168  0,012  CYP2A6 inhibitor
0,159  0,005  Narcotic antagonist
0,183  0,032  Antihyperlipoproteinemic
0,150  0,005  Aldosterone antagonist
0,192  0,047  Diuretic
0,175  0,031  Adenylate cyclase stimulant
0,157  0,016  Opioid mu receptor antagonist
0,140  0,004  5-Alpha-reductase 2 inhibitor
0,140  0,004  5-Alpha-reductase 1 inhibitor
0,188  0,058  UGT1A3 substrate
0,142  0,013  HIV-1 integrase (Strand Transfer) inhibitor
0,125  0,004  Glucocorticoid antagonist
0,148  0,030  Antiviral (Influenza B)
0,128  0,012  Na+ K+ transporting ATPase inhibitor
0,147  0,031  Antineoplastic antibiotic
0,142  0,027  Estrogen antagonist
0,220  0,105  Flavin-containing monooxygenase substrate
0,174  0,060  Antiviral (Herpes)
0,116  0,004  Retinoid X receptor agonist
0,200  0,087  Antiparasitic
0,156  0,046  DNA polymerase I inhibitor
0,193  0,084  Neurotrophic factor enhancer
0,111  0,004  Lipocortins synthesis agonist
0,144  0,036  GABA C receptor agonist
0,158  0,053  Antifungal enhancer
0,226  0,121  CYP1A2 substrate
0,112  0,008  Progesterone antagonist
0,128  0,025  Antibiotic
0,117  0,015  Cushing's syndrome treatment
0,106  0,005  Postcoital contraceptive
0,140  0,040  Expectorant
0,208  0,111  DNA synthesis inhibitor
0,116  0,020  Glycine receptor antagonist
0,158  0,063  Protein kinase stimulant
0,115  0,020  Estrogen receptor alpha antagonist
0,149  0,055  Pregnane X receptor agonist
0,135  0,042  Choleretic
0,111  0,019  Aromatase inhibitor
0,135  0,044  SULT1A1 substrate
0,214  0,124  Antineoplastic (colorectal cancer)
0,098  0,009  SULT2A1 substrate
0,133  0,044  Photosensitizer
0,199  0,110  Vascular (periferal) disease treatment
0,106  0,018  Ca(v)3.1 blocker
0,091  0,004  Hypogonadism treatment
0,127  0,040  Sulfotransferase substrate
0,110  0,024  Vanilloid agonist
0,101  0,020  Glycine receptor agonist
0,138  0,058  Antihemorrhagic
0,104  0,025  HIV-1 integrase (3'-Processing) inhibitor
0,086  0,007  RNA-directed RNA polymerase stimulant
0,148  0,070  Antineoplastic (carcinoma)
0,095  0,019  Estrogen agonist
0,123  0,050  GABA C receptor antagonist
0,196  0,126  Antineoplastic (colon cancer)
0,141  0,073  Antifungal (Cryptococcus)
0,121  0,053  Mucolytic
0,078  0,012  Mineralocorticoid receptor antagonist
0,074  0,008  Retinoid X alpha receptor agonist
0,088  0,027  Dysmenorrhea treatment
0,162  0,101  Antirickettsial
0,128  0,070  Vanilloid 1 agonist
0,063  0,006  Kainate receptor agonist
0,096  0,039  Antiprotozoal activity enhancer
0,070  0,014  Pregnane X receptor antagonist
0,179  0,123  Vasodilator
0,215  0,161  GST M1-1 substrate
0,097  0,044  Antispirochetal
0,132  0,079  Farnesoid X receptor antagonist
0,153  0,101  Phospholipase C inhibitor
0,105  0,055  Estrogen receptor beta antagonist
0,068  0,019  Plasminogen activator inhibitor antagonist
0,083  0,035  Opioid delta receptor antagonist
0,052  0,004  Glucocorticoid agonist
0,135  0,087  Antianemic
0,097  0,055  Bile acid receptor antagonist
0,074  0,032  Glutamate (mGluR6) antagonist
0,091  0,050  Transcription factor NF kappa B stimulant
0,143  0,102  Antipruritic
0,114  0,073  Constipation treatment
0,138  0,098  Growth hormone agonist
0,104  0,064  Carcinogenic, group 2B
0,139  0,100  Muscle relaxant
0,070  0,032  Antimycoplasmal
0,110  0,072  TRPA1 agonist
0,170  0,133  Cytostatic
0,048  0,014  Retinoid X receptor antagonist
0,054  0,021  Opioid kappa receptor agonist
0,171  0,139  Antineoplastic (liver cancer)
0,117  0,085  Anesthetic
0,041  0,011  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,042  0,012  Retinoid X alpha receptor antagonist
0,035  0,005  Corticosteroid-like
0,200  0,170  Caspase 3 stimulant
0,148  0,118  Toxic, respiratory center
0,035  0,006  Progesterone agonist
0,101  0,073  DOPA decarboxylase inhibitor
0,191  0,163  Gastrin inhibitor
0,036  0,008  Retinoid X gamma receptor agonist
0,032  0,004  Retinoid X beta receptor antagonist
0,172  0,145  Hypoglycemic
0,143  0,118  Antihelmintic
0,032  0,008  Retinoid X beta receptor agonist
0,033  0,009  Retinoid X gamma receptor antagonist
0,063  0,041  NMDA 2C receptor antagonist
0,073  0,053  CDC25A inhibitor
0,064  0,044  Calcium channel P-type blocker
0,049  0,029  Microtubule stabilization
0,187  0,169  Hypoxia-inducible factor 1 alpha inhibitor
0,042  0,024  Membrane dipeptidase inhibitor
0,191  0,174  Antiallergic
0,133  0,117  Carcinogenic, group 1
0,084  0,069  Triose-phosphate isomerase inhibitor
0,052  0,040  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,033  0,020  ATP citrate lysase inhibitor
0,121  0,109  Genotoxic
0,210  0,199  Calcium channel activator
0,182  0,171  Tyrosine 3 hydroxylase inhibitor
0,050  0,040  Protein 50S ribosomal subunit inhibitor
0,059  0,049  Heme oxygenase stimulant
0,064  0,054  Premenstrual syndrome treatment
0,066  0,056  Andropause treatment
0,026  0,016  Vanilloid 2 agonist
0,091  0,081  Ferrochelatase inhibitor
0,014  0,005  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,034  0,025  HMG CoA reductase inhibitor
0,081  0,073  Antineoplastic, alkylator
0,048  0,042  Aconitate hydratase inhibitor
0,118  0,111  SULT1A3 substrate
0,135  0,129  Septic shock treatment
0,019  0,014  Progesterone receptor B antagonist
0,008  0,003  Transcortin receptor antagonist
0,082  0,078  SULT1E1 substrate
0,092  0,087  Protein-tyrosine phosphatase 1B inhibitor
0,134  0,130  Antineoplastic (gastric cancer)
0,032  0,028  Tubulin agonist
0,015  0,011  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,090  0,089  Toll-Like receptor 4 antagonist

